Recent studies have demonstrated a complex association between polymorphisms in the FTO gene (fat mass and obesity-associated gene) and the risk of sarcopenia, influenced by population differences, varying diagnostic criteria, and environmental factors [22]. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.